Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins

E-ISSN： 1873-5592|11|6|699-707

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.6, 2010-06, pp. : 699-707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcl-2 Family Proteins as Therapeutic Targets

Current Pharmaceutical Design, Vol. 16, Iss. 28, 2010-09 ,pp. : 3132-3148

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1387-1398

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Bcl-2 family for cancer therapy

By Thomas Shibu Quinn Bridget A Das Swadesh K Dash Rupesh Emdad Luni Dasgupta Santanu Wang Xiang-Yang Dent Paul Reed John C Pellecchia Maurizio Sarkar Devanand Fisher Paul B

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Targeting the BH3 Domain of Bcl-2 Family Proteins. A Brief History From Natural Products to Foldamers As Promising Cancer Therapeutic Avenues

Current Medicinal Chemistry, Vol. 20, Iss. 24, 2013-08 ,pp. : 2964-2978

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

Current Molecular Pharmacology, Vol. 1, Iss. 3, 2008-11 ,pp. : 244-254

Bentham Science Publishers

Access to resources Recommend Favorite